Drug companies with Most Favored Nation pricing deals with the Trump administration are exempt, as are generic drugs, biosimilars, and related ingredients.
The functionally closed system is designed to reduce manual intervention and improve batch-to-batch consistency in cell therapy formulation and filling workflows.
